Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Depyrogenated Sterile Empty Vials Market

ID: MRFR/HC/38717-HCR
100 Pages
Rahul Gotadki
Last Updated: April 24, 2026

Dehydrogenated Sterile Empty Vials Market Research Report By Material Type (Glass, Plastic, Other Materials (e.g., Polypropylene, Cyclo Olefin Copolymer)), By Capacity (Less than 10mL, 10-20mL, 20-30mL, Greater than 30mL), By Closure Type (Rubber Stopper, Flip-Off Caps, Screw Caps, Crimp Caps), By Sterilization Method (Autoclaving, Dry Heat Sterilization, E-beam Radiation, Gamma Radiation), By End-Use Application (Pharmaceuticals, Biotechnology, Diagnostics, Research and Development) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Depyrogenated Sterile Empty Vials Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Material Type (USD Billion)
  49.     4.1.1 Glass
  50.     4.1.2 Plastic
  51.     4.1.3 Other Materials
  52.   4.2 Healthcare, BY Capacity (USD Billion)
  53.     4.2.1 Less than 10mL
  54.     4.2.2 10-20mL
  55.     4.2.3 20-30mL
  56.     4.2.4 Greater than 30mL
  57.   4.3 Healthcare, BY Closure Type (USD Billion)
  58.     4.3.1 Rubber Stopper
  59.     4.3.2 Flip-Off Caps
  60.     4.3.3 Screw Caps
  61.     4.3.4 Crimp Caps
  62.   4.4 Healthcare, BY Sterilization Method (USD Billion)
  63.     4.4.1 Autoclaving
  64.     4.4.2 Dry Heat Sterilization
  65.     4.4.3 E-beam Radiation
  66.     4.4.4 Gamma Radiation
  67.   4.5 Healthcare, BY End-Use Application (USD Billion)
  68.     4.5.1 Pharmaceuticals
  69.     4.5.2 Biotechnology
  70.     4.5.3 Diagnostics
  71.     4.5.4 Research and Development
  72.   4.6 Healthcare, BY Region (USD Billion)
  73.     4.6.1 North America
  74.       4.6.1.1 US
  75.       4.6.1.2 Canada
  76.     4.6.2 Europe
  77.       4.6.2.1 Germany
  78.       4.6.2.2 UK
  79.       4.6.2.3 France
  80.       4.6.2.4 Russia
  81.       4.6.2.5 Italy
  82.       4.6.2.6 Spain
  83.       4.6.2.7 Rest of Europe
  84.     4.6.3 APAC
  85.       4.6.3.1 China
  86.       4.6.3.2 India
  87.       4.6.3.3 Japan
  88.       4.6.3.4 South Korea
  89.       4.6.3.5 Malaysia
  90.       4.6.3.6 Thailand
  91.       4.6.3.7 Indonesia
  92.       4.6.3.8 Rest of APAC
  93.     4.6.4 South America
  94.       4.6.4.1 Brazil
  95.       4.6.4.2 Mexico
  96.       4.6.4.3 Argentina
  97.       4.6.4.4 Rest of South America
  98.     4.6.5 MEA
  99.       4.6.5.1 GCC Countries
  100.       4.6.5.2 South Africa
  101.       4.6.5.3 Rest of MEA
  102. 5 SECTION V: COMPETITIVE ANALYSIS
  103.   5.1 Competitive Landscape
  104.     5.1.1 Overview
  105.     5.1.2 Competitive Analysis
  106.     5.1.3 Market share Analysis
  107.     5.1.4 Major Growth Strategy in the Healthcare
  108.     5.1.5 Competitive Benchmarking
  109.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  110.     5.1.7 Key developments and growth strategies
  111.       5.1.7.1 New Product Launch/Service Deployment
  112.       5.1.7.2 Merger & Acquisitions
  113.       5.1.7.3 Joint Ventures
  114.     5.1.8 Major Players Financial Matrix
  115.       5.1.8.1 Sales and Operating Income
  116.       5.1.8.2 Major Players R&D Expenditure. 2023
  117.   5.2 Company Profiles
  118.     5.2.1 Schott AG (DE)
  119.       5.2.1.1 Financial Overview
  120.       5.2.1.2 Products Offered
  121.       5.2.1.3 Key Developments
  122.       5.2.1.4 SWOT Analysis
  123.       5.2.1.5 Key Strategies
  124.     5.2.2 Gerresheimer AG (DE)
  125.       5.2.2.1 Financial Overview
  126.       5.2.2.2 Products Offered
  127.       5.2.2.3 Key Developments
  128.       5.2.2.4 SWOT Analysis
  129.       5.2.2.5 Key Strategies
  130.     5.2.3 West Pharmaceutical Services Inc (US)
  131.       5.2.3.1 Financial Overview
  132.       5.2.3.2 Products Offered
  133.       5.2.3.3 Key Developments
  134.       5.2.3.4 SWOT Analysis
  135.       5.2.3.5 Key Strategies
  136.     5.2.4 Bormioli Pharma S.p.A. (IT)
  137.       5.2.4.1 Financial Overview
  138.       5.2.4.2 Products Offered
  139.       5.2.4.3 Key Developments
  140.       5.2.4.4 SWOT Analysis
  141.       5.2.4.5 Key Strategies
  142.     5.2.5 Nipro Corporation (JP)
  143.       5.2.5.1 Financial Overview
  144.       5.2.5.2 Products Offered
  145.       5.2.5.3 Key Developments
  146.       5.2.5.4 SWOT Analysis
  147.       5.2.5.5 Key Strategies
  148.     5.2.6 AptarGroup Inc (US)
  149.       5.2.6.1 Financial Overview
  150.       5.2.6.2 Products Offered
  151.       5.2.6.3 Key Developments
  152.       5.2.6.4 SWOT Analysis
  153.       5.2.6.5 Key Strategies
  154.     5.2.7 Sartorius AG (DE)
  155.       5.2.7.1 Financial Overview
  156.       5.2.7.2 Products Offered
  157.       5.2.7.3 Key Developments
  158.       5.2.7.4 SWOT Analysis
  159.       5.2.7.5 Key Strategies
  160.     5.2.8 Medtronic plc (IE)
  161.       5.2.8.1 Financial Overview
  162.       5.2.8.2 Products Offered
  163.       5.2.8.3 Key Developments
  164.       5.2.8.4 SWOT Analysis
  165.       5.2.8.5 Key Strategies
  166.     5.2.9 Stevanato Group S.p.A. (IT)
  167.       5.2.9.1 Financial Overview
  168.       5.2.9.2 Products Offered
  169.       5.2.9.3 Key Developments
  170.       5.2.9.4 SWOT Analysis
  171.       5.2.9.5 Key Strategies
  172.   5.3 Appendix
  173.     5.3.1 References
  174.     5.3.2 Related Reports
  175. 6 LIST OF FIGURES
  176.   6.1 MARKET SYNOPSIS
  177.   6.2 NORTH AMERICA MARKET ANALYSIS
  178.   6.3 US MARKET ANALYSIS BY MATERIAL TYPE
  179.   6.4 US MARKET ANALYSIS BY CAPACITY
  180.   6.5 US MARKET ANALYSIS BY CLOSURE TYPE
  181.   6.6 US MARKET ANALYSIS BY STERILIZATION METHOD
  182.   6.7 US MARKET ANALYSIS BY END-USE APPLICATION
  183.   6.8 CANADA MARKET ANALYSIS BY MATERIAL TYPE
  184.   6.9 CANADA MARKET ANALYSIS BY CAPACITY
  185.   6.10 CANADA MARKET ANALYSIS BY CLOSURE TYPE
  186.   6.11 CANADA MARKET ANALYSIS BY STERILIZATION METHOD
  187.   6.12 CANADA MARKET ANALYSIS BY END-USE APPLICATION
  188.   6.13 EUROPE MARKET ANALYSIS
  189.   6.14 GERMANY MARKET ANALYSIS BY MATERIAL TYPE
  190.   6.15 GERMANY MARKET ANALYSIS BY CAPACITY
  191.   6.16 GERMANY MARKET ANALYSIS BY CLOSURE TYPE
  192.   6.17 GERMANY MARKET ANALYSIS BY STERILIZATION METHOD
  193.   6.18 GERMANY MARKET ANALYSIS BY END-USE APPLICATION
  194.   6.19 UK MARKET ANALYSIS BY MATERIAL TYPE
  195.   6.20 UK MARKET ANALYSIS BY CAPACITY
  196.   6.21 UK MARKET ANALYSIS BY CLOSURE TYPE
  197.   6.22 UK MARKET ANALYSIS BY STERILIZATION METHOD
  198.   6.23 UK MARKET ANALYSIS BY END-USE APPLICATION
  199.   6.24 FRANCE MARKET ANALYSIS BY MATERIAL TYPE
  200.   6.25 FRANCE MARKET ANALYSIS BY CAPACITY
  201.   6.26 FRANCE MARKET ANALYSIS BY CLOSURE TYPE
  202.   6.27 FRANCE MARKET ANALYSIS BY STERILIZATION METHOD
  203.   6.28 FRANCE MARKET ANALYSIS BY END-USE APPLICATION
  204.   6.29 RUSSIA MARKET ANALYSIS BY MATERIAL TYPE
  205.   6.30 RUSSIA MARKET ANALYSIS BY CAPACITY
  206.   6.31 RUSSIA MARKET ANALYSIS BY CLOSURE TYPE
  207.   6.32 RUSSIA MARKET ANALYSIS BY STERILIZATION METHOD
  208.   6.33 RUSSIA MARKET ANALYSIS BY END-USE APPLICATION
  209.   6.34 ITALY MARKET ANALYSIS BY MATERIAL TYPE
  210.   6.35 ITALY MARKET ANALYSIS BY CAPACITY
  211.   6.36 ITALY MARKET ANALYSIS BY CLOSURE TYPE
  212.   6.37 ITALY MARKET ANALYSIS BY STERILIZATION METHOD
  213.   6.38 ITALY MARKET ANALYSIS BY END-USE APPLICATION
  214.   6.39 SPAIN MARKET ANALYSIS BY MATERIAL TYPE
  215.   6.40 SPAIN MARKET ANALYSIS BY CAPACITY
  216.   6.41 SPAIN MARKET ANALYSIS BY CLOSURE TYPE
  217.   6.42 SPAIN MARKET ANALYSIS BY STERILIZATION METHOD
  218.   6.43 SPAIN MARKET ANALYSIS BY END-USE APPLICATION
  219.   6.44 REST OF EUROPE MARKET ANALYSIS BY MATERIAL TYPE
  220.   6.45 REST OF EUROPE MARKET ANALYSIS BY CAPACITY
  221.   6.46 REST OF EUROPE MARKET ANALYSIS BY CLOSURE TYPE
  222.   6.47 REST OF EUROPE MARKET ANALYSIS BY STERILIZATION METHOD
  223.   6.48 REST OF EUROPE MARKET ANALYSIS BY END-USE APPLICATION
  224.   6.49 APAC MARKET ANALYSIS
  225.   6.50 CHINA MARKET ANALYSIS BY MATERIAL TYPE
  226.   6.51 CHINA MARKET ANALYSIS BY CAPACITY
  227.   6.52 CHINA MARKET ANALYSIS BY CLOSURE TYPE
  228.   6.53 CHINA MARKET ANALYSIS BY STERILIZATION METHOD
  229.   6.54 CHINA MARKET ANALYSIS BY END-USE APPLICATION
  230.   6.55 INDIA MARKET ANALYSIS BY MATERIAL TYPE
  231.   6.56 INDIA MARKET ANALYSIS BY CAPACITY
  232.   6.57 INDIA MARKET ANALYSIS BY CLOSURE TYPE
  233.   6.58 INDIA MARKET ANALYSIS BY STERILIZATION METHOD
  234.   6.59 INDIA MARKET ANALYSIS BY END-USE APPLICATION
  235.   6.60 JAPAN MARKET ANALYSIS BY MATERIAL TYPE
  236.   6.61 JAPAN MARKET ANALYSIS BY CAPACITY
  237.   6.62 JAPAN MARKET ANALYSIS BY CLOSURE TYPE
  238.   6.63 JAPAN MARKET ANALYSIS BY STERILIZATION METHOD
  239.   6.64 JAPAN MARKET ANALYSIS BY END-USE APPLICATION
  240.   6.65 SOUTH KOREA MARKET ANALYSIS BY MATERIAL TYPE
  241.   6.66 SOUTH KOREA MARKET ANALYSIS BY CAPACITY
  242.   6.67 SOUTH KOREA MARKET ANALYSIS BY CLOSURE TYPE
  243.   6.68 SOUTH KOREA MARKET ANALYSIS BY STERILIZATION METHOD
  244.   6.69 SOUTH KOREA MARKET ANALYSIS BY END-USE APPLICATION
  245.   6.70 MALAYSIA MARKET ANALYSIS BY MATERIAL TYPE
  246.   6.71 MALAYSIA MARKET ANALYSIS BY CAPACITY
  247.   6.72 MALAYSIA MARKET ANALYSIS BY CLOSURE TYPE
  248.   6.73 MALAYSIA MARKET ANALYSIS BY STERILIZATION METHOD
  249.   6.74 MALAYSIA MARKET ANALYSIS BY END-USE APPLICATION
  250.   6.75 THAILAND MARKET ANALYSIS BY MATERIAL TYPE
  251.   6.76 THAILAND MARKET ANALYSIS BY CAPACITY
  252.   6.77 THAILAND MARKET ANALYSIS BY CLOSURE TYPE
  253.   6.78 THAILAND MARKET ANALYSIS BY STERILIZATION METHOD
  254.   6.79 THAILAND MARKET ANALYSIS BY END-USE APPLICATION
  255.   6.80 INDONESIA MARKET ANALYSIS BY MATERIAL TYPE
  256.   6.81 INDONESIA MARKET ANALYSIS BY CAPACITY
  257.   6.82 INDONESIA MARKET ANALYSIS BY CLOSURE TYPE
  258.   6.83 INDONESIA MARKET ANALYSIS BY STERILIZATION METHOD
  259.   6.84 INDONESIA MARKET ANALYSIS BY END-USE APPLICATION
  260.   6.85 REST OF APAC MARKET ANALYSIS BY MATERIAL TYPE
  261.   6.86 REST OF APAC MARKET ANALYSIS BY CAPACITY
  262.   6.87 REST OF APAC MARKET ANALYSIS BY CLOSURE TYPE
  263.   6.88 REST OF APAC MARKET ANALYSIS BY STERILIZATION METHOD
  264.   6.89 REST OF APAC MARKET ANALYSIS BY END-USE APPLICATION
  265.   6.90 SOUTH AMERICA MARKET ANALYSIS
  266.   6.91 BRAZIL MARKET ANALYSIS BY MATERIAL TYPE
  267.   6.92 BRAZIL MARKET ANALYSIS BY CAPACITY
  268.   6.93 BRAZIL MARKET ANALYSIS BY CLOSURE TYPE
  269.   6.94 BRAZIL MARKET ANALYSIS BY STERILIZATION METHOD
  270.   6.95 BRAZIL MARKET ANALYSIS BY END-USE APPLICATION
  271.   6.96 MEXICO MARKET ANALYSIS BY MATERIAL TYPE
  272.   6.97 MEXICO MARKET ANALYSIS BY CAPACITY
  273.   6.98 MEXICO MARKET ANALYSIS BY CLOSURE TYPE
  274.   6.99 MEXICO MARKET ANALYSIS BY STERILIZATION METHOD
  275.   6.100 MEXICO MARKET ANALYSIS BY END-USE APPLICATION
  276.   6.101 ARGENTINA MARKET ANALYSIS BY MATERIAL TYPE
  277.   6.102 ARGENTINA MARKET ANALYSIS BY CAPACITY
  278.   6.103 ARGENTINA MARKET ANALYSIS BY CLOSURE TYPE
  279.   6.104 ARGENTINA MARKET ANALYSIS BY STERILIZATION METHOD
  280.   6.105 ARGENTINA MARKET ANALYSIS BY END-USE APPLICATION
  281.   6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY MATERIAL TYPE
  282.   6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY CAPACITY
  283.   6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY CLOSURE TYPE
  284.   6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY STERILIZATION METHOD
  285.   6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY END-USE APPLICATION
  286.   6.111 MEA MARKET ANALYSIS
  287.   6.112 GCC COUNTRIES MARKET ANALYSIS BY MATERIAL TYPE
  288.   6.113 GCC COUNTRIES MARKET ANALYSIS BY CAPACITY
  289.   6.114 GCC COUNTRIES MARKET ANALYSIS BY CLOSURE TYPE
  290.   6.115 GCC COUNTRIES MARKET ANALYSIS BY STERILIZATION METHOD
  291.   6.116 GCC COUNTRIES MARKET ANALYSIS BY END-USE APPLICATION
  292.   6.117 SOUTH AFRICA MARKET ANALYSIS BY MATERIAL TYPE
  293.   6.118 SOUTH AFRICA MARKET ANALYSIS BY CAPACITY
  294.   6.119 SOUTH AFRICA MARKET ANALYSIS BY CLOSURE TYPE
  295.   6.120 SOUTH AFRICA MARKET ANALYSIS BY STERILIZATION METHOD
  296.   6.121 SOUTH AFRICA MARKET ANALYSIS BY END-USE APPLICATION
  297.   6.122 REST OF MEA MARKET ANALYSIS BY MATERIAL TYPE
  298.   6.123 REST OF MEA MARKET ANALYSIS BY CAPACITY
  299.   6.124 REST OF MEA MARKET ANALYSIS BY CLOSURE TYPE
  300.   6.125 REST OF MEA MARKET ANALYSIS BY STERILIZATION METHOD
  301.   6.126 REST OF MEA MARKET ANALYSIS BY END-USE APPLICATION
  302.   6.127 KEY BUYING CRITERIA OF HEALTHCARE
  303.   6.128 RESEARCH PROCESS OF MRFR
  304.   6.129 DRO ANALYSIS OF HEALTHCARE
  305.   6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  306.   6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  307.   6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
  308.   6.133 HEALTHCARE, BY MATERIAL TYPE, 2024 (% SHARE)
  309.   6.134 HEALTHCARE, BY MATERIAL TYPE, 2024 TO 2035 (USD Billion)
  310.   6.135 HEALTHCARE, BY CAPACITY, 2024 (% SHARE)
  311.   6.136 HEALTHCARE, BY CAPACITY, 2024 TO 2035 (USD Billion)
  312.   6.137 HEALTHCARE, BY CLOSURE TYPE, 2024 (% SHARE)
  313.   6.138 HEALTHCARE, BY CLOSURE TYPE, 2024 TO 2035 (USD Billion)
  314.   6.139 HEALTHCARE, BY STERILIZATION METHOD, 2024 (% SHARE)
  315.   6.140 HEALTHCARE, BY STERILIZATION METHOD, 2024 TO 2035 (USD Billion)
  316.   6.141 HEALTHCARE, BY END-USE APPLICATION, 2024 (% SHARE)
  317.   6.142 HEALTHCARE, BY END-USE APPLICATION, 2024 TO 2035 (USD Billion)
  318.   6.143 BENCHMARKING OF MAJOR COMPETITORS
  319. 7 LIST OF TABLES
  320.   7.1 LIST OF ASSUMPTIONS
  321.     7.1.1
  322.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  323.     7.2.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
  324.     7.2.2 BY CAPACITY, 2025-2035 (USD Billion)
  325.     7.2.3 BY CLOSURE TYPE, 2025-2035 (USD Billion)
  326.     7.2.4 BY STERILIZATION METHOD, 2025-2035 (USD Billion)
  327.     7.2.5 BY END-USE APPLICATION, 2025-2035 (USD Billion)
  328.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  329.     7.3.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
  330.     7.3.2 BY CAPACITY, 2025-2035 (USD Billion)
  331.     7.3.3 BY CLOSURE TYPE, 2025-2035 (USD Billion)
  332.     7.3.4 BY STERILIZATION METHOD, 2025-2035 (USD Billion)
  333.     7.3.5 BY END-USE APPLICATION, 2025-2035 (USD Billion)
  334.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  335.     7.4.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
  336.     7.4.2 BY CAPACITY, 2025-2035 (USD Billion)
  337.     7.4.3 BY CLOSURE TYPE, 2025-2035 (USD Billion)
  338.     7.4.4 BY STERILIZATION METHOD, 2025-2035 (USD Billion)
  339.     7.4.5 BY END-USE APPLICATION, 2025-2035 (USD Billion)
  340.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  341.     7.5.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
  342.     7.5.2 BY CAPACITY, 2025-2035 (USD Billion)
  343.     7.5.3 BY CLOSURE TYPE, 2025-2035 (USD Billion)
  344.     7.5.4 BY STERILIZATION METHOD, 2025-2035 (USD Billion)
  345.     7.5.5 BY END-USE APPLICATION, 2025-2035 (USD Billion)
  346.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  347.     7.6.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
  348.     7.6.2 BY CAPACITY, 2025-2035 (USD Billion)
  349.     7.6.3 BY CLOSURE TYPE, 2025-2035 (USD Billion)
  350.     7.6.4 BY STERILIZATION METHOD, 2025-2035 (USD Billion)
  351.     7.6.5 BY END-USE APPLICATION, 2025-2035 (USD Billion)
  352.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  353.     7.7.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
  354.     7.7.2 BY CAPACITY, 2025-2035 (USD Billion)
  355.     7.7.3 BY CLOSURE TYPE, 2025-2035 (USD Billion)
  356.     7.7.4 BY STERILIZATION METHOD, 2025-2035 (USD Billion)
  357.     7.7.5 BY END-USE APPLICATION, 2025-2035 (USD Billion)
  358.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  359.     7.8.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
  360.     7.8.2 BY CAPACITY, 2025-2035 (USD Billion)
  361.     7.8.3 BY CLOSURE TYPE, 2025-2035 (USD Billion)
  362.     7.8.4 BY STERILIZATION METHOD, 2025-2035 (USD Billion)
  363.     7.8.5 BY END-USE APPLICATION, 2025-2035 (USD Billion)
  364.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  365.     7.9.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
  366.     7.9.2 BY CAPACITY, 2025-2035 (USD Billion)
  367.     7.9.3 BY CLOSURE TYPE, 2025-2035 (USD Billion)
  368.     7.9.4 BY STERILIZATION METHOD, 2025-2035 (USD Billion)
  369.     7.9.5 BY END-USE APPLICATION, 2025-2035 (USD Billion)
  370.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  371.     7.10.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
  372.     7.10.2 BY CAPACITY, 2025-2035 (USD Billion)
  373.     7.10.3 BY CLOSURE TYPE, 2025-2035 (USD Billion)
  374.     7.10.4 BY STERILIZATION METHOD, 2025-2035 (USD Billion)
  375.     7.10.5 BY END-USE APPLICATION, 2025-2035 (USD Billion)
  376.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  377.     7.11.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
  378.     7.11.2 BY CAPACITY, 2025-2035 (USD Billion)
  379.     7.11.3 BY CLOSURE TYPE, 2025-2035 (USD Billion)
  380.     7.11.4 BY STERILIZATION METHOD, 2025-2035 (USD Billion)
  381.     7.11.5 BY END-USE APPLICATION, 2025-2035 (USD Billion)
  382.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  383.     7.12.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
  384.     7.12.2 BY CAPACITY, 2025-2035 (USD Billion)
  385.     7.12.3 BY CLOSURE TYPE, 2025-2035 (USD Billion)
  386.     7.12.4 BY STERILIZATION METHOD, 2025-2035 (USD Billion)
  387.     7.12.5 BY END-USE APPLICATION, 2025-2035 (USD Billion)
  388.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  389.     7.13.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
  390.     7.13.2 BY CAPACITY, 2025-2035 (USD Billion)
  391.     7.13.3 BY CLOSURE TYPE, 2025-2035 (USD Billion)
  392.     7.13.4 BY STERILIZATION METHOD, 2025-2035 (USD Billion)
  393.     7.13.5 BY END-USE APPLICATION, 2025-2035 (USD Billion)
  394.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  395.     7.14.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
  396.     7.14.2 BY CAPACITY, 2025-2035 (USD Billion)
  397.     7.14.3 BY CLOSURE TYPE, 2025-2035 (USD Billion)
  398.     7.14.4 BY STERILIZATION METHOD, 2025-2035 (USD Billion)
  399.     7.14.5 BY END-USE APPLICATION, 2025-2035 (USD Billion)
  400.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  401.     7.15.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
  402.     7.15.2 BY CAPACITY, 2025-2035 (USD Billion)
  403.     7.15.3 BY CLOSURE TYPE, 2025-2035 (USD Billion)
  404.     7.15.4 BY STERILIZATION METHOD, 2025-2035 (USD Billion)
  405.     7.15.5 BY END-USE APPLICATION, 2025-2035 (USD Billion)
  406.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  407.     7.16.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
  408.     7.16.2 BY CAPACITY, 2025-2035 (USD Billion)
  409.     7.16.3 BY CLOSURE TYPE, 2025-2035 (USD Billion)
  410.     7.16.4 BY STERILIZATION METHOD, 2025-2035 (USD Billion)
  411.     7.16.5 BY END-USE APPLICATION, 2025-2035 (USD Billion)
  412.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  413.     7.17.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
  414.     7.17.2 BY CAPACITY, 2025-2035 (USD Billion)
  415.     7.17.3 BY CLOSURE TYPE, 2025-2035 (USD Billion)
  416.     7.17.4 BY STERILIZATION METHOD, 2025-2035 (USD Billion)
  417.     7.17.5 BY END-USE APPLICATION, 2025-2035 (USD Billion)
  418.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  419.     7.18.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
  420.     7.18.2 BY CAPACITY, 2025-2035 (USD Billion)
  421.     7.18.3 BY CLOSURE TYPE, 2025-2035 (USD Billion)
  422.     7.18.4 BY STERILIZATION METHOD, 2025-2035 (USD Billion)
  423.     7.18.5 BY END-USE APPLICATION, 2025-2035 (USD Billion)
  424.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  425.     7.19.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
  426.     7.19.2 BY CAPACITY, 2025-2035 (USD Billion)
  427.     7.19.3 BY CLOSURE TYPE, 2025-2035 (USD Billion)
  428.     7.19.4 BY STERILIZATION METHOD, 2025-2035 (USD Billion)
  429.     7.19.5 BY END-USE APPLICATION, 2025-2035 (USD Billion)
  430.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  431.     7.20.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
  432.     7.20.2 BY CAPACITY, 2025-2035 (USD Billion)
  433.     7.20.3 BY CLOSURE TYPE, 2025-2035 (USD Billion)
  434.     7.20.4 BY STERILIZATION METHOD, 2025-2035 (USD Billion)
  435.     7.20.5 BY END-USE APPLICATION, 2025-2035 (USD Billion)
  436.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  437.     7.21.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
  438.     7.21.2 BY CAPACITY, 2025-2035 (USD Billion)
  439.     7.21.3 BY CLOSURE TYPE, 2025-2035 (USD Billion)
  440.     7.21.4 BY STERILIZATION METHOD, 2025-2035 (USD Billion)
  441.     7.21.5 BY END-USE APPLICATION, 2025-2035 (USD Billion)
  442.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  443.     7.22.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
  444.     7.22.2 BY CAPACITY, 2025-2035 (USD Billion)
  445.     7.22.3 BY CLOSURE TYPE, 2025-2035 (USD Billion)
  446.     7.22.4 BY STERILIZATION METHOD, 2025-2035 (USD Billion)
  447.     7.22.5 BY END-USE APPLICATION, 2025-2035 (USD Billion)
  448.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  449.     7.23.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
  450.     7.23.2 BY CAPACITY, 2025-2035 (USD Billion)
  451.     7.23.3 BY CLOSURE TYPE, 2025-2035 (USD Billion)
  452.     7.23.4 BY STERILIZATION METHOD, 2025-2035 (USD Billion)
  453.     7.23.5 BY END-USE APPLICATION, 2025-2035 (USD Billion)
  454.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  455.     7.24.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
  456.     7.24.2 BY CAPACITY, 2025-2035 (USD Billion)
  457.     7.24.3 BY CLOSURE TYPE, 2025-2035 (USD Billion)
  458.     7.24.4 BY STERILIZATION METHOD, 2025-2035 (USD Billion)
  459.     7.24.5 BY END-USE APPLICATION, 2025-2035 (USD Billion)
  460.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  461.     7.25.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
  462.     7.25.2 BY CAPACITY, 2025-2035 (USD Billion)
  463.     7.25.3 BY CLOSURE TYPE, 2025-2035 (USD Billion)
  464.     7.25.4 BY STERILIZATION METHOD, 2025-2035 (USD Billion)
  465.     7.25.5 BY END-USE APPLICATION, 2025-2035 (USD Billion)
  466.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  467.     7.26.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
  468.     7.26.2 BY CAPACITY, 2025-2035 (USD Billion)
  469.     7.26.3 BY CLOSURE TYPE, 2025-2035 (USD Billion)
  470.     7.26.4 BY STERILIZATION METHOD, 2025-2035 (USD Billion)
  471.     7.26.5 BY END-USE APPLICATION, 2025-2035 (USD Billion)
  472.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  473.     7.27.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
  474.     7.27.2 BY CAPACITY, 2025-2035 (USD Billion)
  475.     7.27.3 BY CLOSURE TYPE, 2025-2035 (USD Billion)
  476.     7.27.4 BY STERILIZATION METHOD, 2025-2035 (USD Billion)
  477.     7.27.5 BY END-USE APPLICATION, 2025-2035 (USD Billion)
  478.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  479.     7.28.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
  480.     7.28.2 BY CAPACITY, 2025-2035 (USD Billion)
  481.     7.28.3 BY CLOSURE TYPE, 2025-2035 (USD Billion)
  482.     7.28.4 BY STERILIZATION METHOD, 2025-2035 (USD Billion)
  483.     7.28.5 BY END-USE APPLICATION, 2025-2035 (USD Billion)
  484.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  485.     7.29.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
  486.     7.29.2 BY CAPACITY, 2025-2035 (USD Billion)
  487.     7.29.3 BY CLOSURE TYPE, 2025-2035 (USD Billion)
  488.     7.29.4 BY STERILIZATION METHOD, 2025-2035 (USD Billion)
  489.     7.29.5 BY END-USE APPLICATION, 2025-2035 (USD Billion)
  490.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  491.     7.30.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
  492.     7.30.2 BY CAPACITY, 2025-2035 (USD Billion)
  493.     7.30.3 BY CLOSURE TYPE, 2025-2035 (USD Billion)
  494.     7.30.4 BY STERILIZATION METHOD, 2025-2035 (USD Billion)
  495.     7.30.5 BY END-USE APPLICATION, 2025-2035 (USD Billion)
  496.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  497.     7.31.1
  498.   7.32 ACQUISITION/PARTNERSHIP
  499.     7.32.1

Healthcare Market Segmentation

Healthcare By Material Type (USD Billion, 2025-2035)

  • Glass
  • Plastic
  • Other Materials

Healthcare By Capacity (USD Billion, 2025-2035)

  • Less than 10mL
  • 10-20mL
  • 20-30mL
  • Greater than 30mL

Healthcare By Closure Type (USD Billion, 2025-2035)

  • Rubber Stopper
  • Flip-Off Caps
  • Screw Caps
  • Crimp Caps

Healthcare By Sterilization Method (USD Billion, 2025-2035)

  • Autoclaving
  • Dry Heat Sterilization
  • E-beam Radiation
  • Gamma Radiation

Healthcare By End-Use Application (USD Billion, 2025-2035)

  • Pharmaceuticals
  • Biotechnology
  • Diagnostics
  • Research and Development

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions